Clinical Trials
53 trialsA Study of XmAb23104 in People With Sarcoma
Memorial Sloan Kettering Cancer Center
CASSANDRE
Centre Oscar Lambret
PROACT
Washington University School of Medicine
STARBURST
Telix Pharmaceuticals (Innovations) Pty Limited
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Elevation Oncology
TTI-621-03
Pfizer
Milademetan in Advanced/Metastatic Solid Tumors
Rain Oncology Inc
Pazopanib Maintenance Phase II
Ludwig-Maximilians - University of Munich
Palbociclib + Ganitumab In Ewing Sarcoma
Dana-Farber Cancer Institute
UVA-Gen001
University of Virginia
A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Jiangsu HengRui Medicine Co., Ltd.
LODESTAR
pharmaand GmbH
ALpha-T
Hoffmann-La Roche
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
Genentech, Inc.
Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
Fox Chase Cancer Center
A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma
Ludwig Institute for Cancer Research
ANITA
European Organisation for Research and Treatment of Cancer - EORTC
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Hoffmann-La Roche
NOPASS
Heidelberg University
Gemcitabine Plus Ascorbate for Sarcoma in Adults
University of Iowa
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
Jonsson Comprehensive Cancer Center
OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
IMDZ-C232
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
HYPAZ
Cambridge University Hospitals NHS Foundation Trust
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Celgene
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
Columbia University
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Mayo Clinic
PASART-2
The Netherlands Cancer Institute
A Japanese Trial of TH-302 in Subjects With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Merck KGaA, Darmstadt, Germany
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Washington University School of Medicine
Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall
National Cancer Institute (NCI)
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
GOG Foundation
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
Stanford University
18F-Fluoromisonidazole and Fludeoxyglucose F 18 PET/CT Patients With Soft Tissue Sarcoma
National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma
Burzynski Research Institute
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain
National Institutes of Health Clinical Center (CC)
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma
AHS Cancer Control Alberta
A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
Shin Kong Wu Ho-Su Memorial Hospital
Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS
Grupo Espanol de Investigacion en Sarcomas
Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma
National Cancer Institute (NCI)
Phase II Study of Doxorubicin and Avastin® in Sarcoma.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Children's Oncology Group
Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
City of Hope Medical Center
Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Stage IB, Stage II, or Stage III Soft Tissue Sarcoma
City of Hope Medical Center
Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas
H. Lee Moffitt Cancer Center and Research Institute
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
GOG Foundation
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
GOG Foundation
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
GOG Foundation